| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2022 | A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies | Kumari, Monika; Lu, Ruei-Min ; Li, Mu-Chun; Huang, Jhih-Liang; Hsu, Fu-Fei; Ko, Shih-Han; Ke, Feng-Yi; Su, Shih-Chieh; Liang, Kang-Hao; Yuan, Joyce Pei-Yi; Chiang, Hsiao-Ling; Sun, Cheng-Pu; Lee, I.-Jung; Li, Wen-Shan ; Hsieh, Hsing-Pang ; Tao, Mi-Hua ; Wu, Han-Chung | Journal of Biomedical Science 29(1), 68 | | | |
| 2019 | Design of drug-like hepsin inhibitors against prostate cancer and kidney stones | Blay, Vincent; Li, Mu-Chun; Ho, Sunita P.; Stoller, Mashall L.; Hsieh, Hsing-Pang ; Houston, Douglas R. | Acta Pharmaceutica Sinica B 10(7), 1309-1320 | | | |
| 2020 | Drug-like property optimization: Discovery of orally bioavailable quinazoline-based multi-targeted kinase inhibitors | Lin, Shu-Yu; Chang, Chun-Feng; Coumar, Mohane Selvaraj; Chen, Pei-Yi; Kuo, Fu-Ming; Chen, Chun-Hwa; Li, Mu-Chun; Lin, Wen-Hsing; Kuo, Po-Chu; Wang, Sing-Yi; Li, An-Siou; Lin, Chin-Yu; Yang, Chen-Ming; Yeh, Teng-Kuang; Song, Jen-Shin; Hsu, John T.A.; Hsieh, Hsing-Pang | Bioorganic Chemistry 98, 103689 | | | |
